Cuba tops the list of Latin American countries with the highest percentage of the population (80.9) that received at least one dose of some COVID-19 vaccines.
The scope of 20 million doses produced of the Abdala vaccine and the encouraging partial results of effectiveness of the anti-COVID-19 vaccination, in protecting against severe systemic disease and death, were some of the good news that was reported this week regarding the confrontation of the pandemic in Cuba.
The vaccination of pregnant women in their second and third pregnancy quarters and nursing mothers kicked off Thursday 29, said senior researcher with the Cuban Abdala vaccine Marbelis Bordonado.
Cuban authorities assured that the vaccination process for children will begin in September 2021, local press reported.
In fact, clinical trials are been applied to children aging from 3 to 18 years.
The first group of children between 3 and 11 years old included in Cuba’s COVID-19 clinical trial called ‘Soberana-Pediatria’ (‘Soberana-Pedriatics’) is receiving their first dose of Soberana 02 on Monday 28.
The number Cubans who have been immunized with one or more doses of the Abdala and Soberana 02 vaccine candidates against COVID-19, as part of the health intervention in territories and risk groups reached 455,908.
Some 70 thousand Cubans have been immunized with a local COVID-19 candidate vaccine named ABDALA as part of an ongoing health intervention which kicked off on Monday 10, involving health workers, medical students and employees with BioCubaFarma Biotech.
The Cuban anti-COVID-19 Soberana 02 vaccine candidate, which is in a Phase II clinical trial, began to be applied this week through vaccination.
According to the Finlay Vaccine Institute in its official profile on Twitter, this process proceeds normally and in strict compliance with the health regulations and protocols established for these cases.